Item 8.01 Other Events.

On September 14, 2021, Ortho Clinical Diagnostics Holdings plc (the "Company") issued a press release announcing the closing (the "Closing") of the previously announced underwritten secondary offering (the "Offering") of 25,300,000 ordinary shares of the Company, nominal value $0.00001 per share (the "Ordinary Shares"), held by a selling shareholder affiliated with The Carlyle Group (the "Selling Shareholder"), which includes the full exercise by the underwriters of their option to purchase up to 3,300,000 additional Ordinary Shares, at a price of $17.50 per Ordinary Share. As a result of the Closing, the Company is no longer a "controlled company" within the meaning of the rules of the NASDAQ Global Select Market. A copy of this press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.



Exhibit
Number                                  Description
            Press Release issued by Ortho Clinical Diagnostics Holdings plc dated
99.1      September 14, 2021
          Cover Page Interactive Data File (embedded within the Inline XBRL
104       document).








                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses